REN and hypertensive disorder: It should also be considered, however, that a particular pathway sensitive to TZD inhibition, e.g., renin–angiotensin II, could underlie the multiple types of hypertension associated with responders (Guiding Parameters (a) Therapeutic TZD dose/concentration).